Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States.
$32.51-2.02%
报价 2026-11-06
市值
$5.79B
EV
$5.66B
PE (TTM)
37.3x
预期 PE (FY2027)
24.1x
52 周区间距高点 -38.3%
$18.01$52.72
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22028-03 | 1.1x | 1.37 → 1.56（1.1x） | 20.9 |
| FY+32029-03 | 1.2x | 1.37 → 1.86（1.4x） | 17.5 |
毛利率 88% · TTM 收入 $662M · 基数 EPS 1.37（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| DOCSDoximity, Inc. | $5.79B | -2.0% | +5.3% | 84.9% | 37.3x | 23.4x | 19.8x | |
| VTRSViatris Inc. | $22.87B | +5.0% | +4.6% | 38.8% | – | 12.4x | 11.2x | |
| GHGuardant Health, Inc. | $20.25B | -1.7% | +39.5% | 65.4% | – | – | – | 高增长 |
| RVTYRevvity, Inc. | $17.31B | +2.8% | +0.6% | 57.1% | 72.2x | 25.1x | 30.3x | |
| SOLVSolventum Corporation | $15.38B | +3.7% | -0.7% | 53.5% | 7.3x | 5.5x | – | |
| ICLRICON Public Limited Company | $15.34B | +1.5% | +1.6% | 19.6% | 34.7x | 13.4x | 12.2x | |
| EHCEncompass Health Corporation | $13.57B | -2.6% | +9.2% | 21.6% | 21.2x | 10.5x | 29.7x | |
| TEMTempus AI, Inc. | $13.49B | +8.0% | +26.3% | 72.3% | – | – | – | |
| COOThe Cooper Companies, Inc. | $11.86B | -1.8% | +4.0% | 62.4% | 19.1x | 14.6x | 16.1x | |
| 同行中位数 | – | – | +4.3% | 55.3% | 21.2x | 12.9x | 16.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-06-30 Q1 2027 | 2026-03-31 Q4 2026 | 2025-12-31 Q3 2026 | 2025-09-30 Q2 2026 | 2025-06-30 Q1 2026 | 2025-03-31 Q4 2025 | 2024-12-31 Q3 2025 | 2024-09-30 Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $156.6M | $145.4M | $185.1M | $168.5M | $145.9M | $138.3M | $168.6M | $136.8M |
| Gross Margin | 84.9% | 86.7% | 89.9% | 90.3% | 89.2% | 89.5% | 91.6% | 90% |
| Operating Margin | 21.5% | 17.1% | 38.9% | 37.8% | 37.4% | 35.2% | 47.4% | 38.8% |
| Net Income | $24.3M | $19.1M | $61.6M | $62.1M | $53.3M | $62.5M | $75.2M | $44.2M |
| Diluted EPS | 0.13 | 0.1 | 0.31 | 0.31 | 0.27 | 0.31 | 0.37 | 0.22 |
| Operating Cash Flow | $42M | $109.5M | $60.9M | $93.9M | $62.1M | $98.5M | $65.2M | $68.3M |
研究材料
电话会纪要摘要
暂无纪要摘要。